Ausdal Financial Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.66M Buy
19,068
+2,480
+15% +$578K 0.21% 121
2025
Q4
$3.43M Sell
16,588
-62
-0.4% -$12.3K 0.16% 154
2025
Q3
$3.09M Buy
16,650
+3,625
+28% +$621K 0.15% 160
2025
Q2
$1.99M Sell
13,025
-701
-5% -$108K 0.13% 157
2025
Q1
$2.28M Buy
13,726
+3,898
+40% +$610K 0.17% 134
2024
Q4
$1.42M Buy
9,828
+527
+6% +$81.7K 0.12% 166
2024
Q3
$1.51M Sell
9,301
-353
-4% -$56.2K 0.16% 137
2024
Q2
$1.41M Sell
9,654
-63
-0.6% -$9.37K 0.15% 142
2024
Q1
$1.54M Sell
9,717
-217
-2% -$34.5K 0.18% 127
2023
Q4
$1.56M Sell
9,934
-343
-3% -$52.6K 0.19% 118
2023
Q3
$1.6M Sell
10,277
-1,495
-13% -$247K 0.22% 112
2023
Q2
$1.95M Sell
11,772
-447
-4% -$72.1K 0.26% 96
2023
Q1
$1.89M Sell
12,219
-380
-3% -$61.4K 0.26% 100
2022
Q4
$2.23M Buy
12,599
+542
+4% +$93.6K 0.32% 77
2022
Q3
$1.97M Sell
12,057
-9
-0.1% -$1.52K 0.31% 82
2022
Q2
$2.14M Sell
12,066
-251
-2% -$44.7K 0.32% 89
2022
Q1
$2.18M Sell
12,317
-76
-0.6% -$12.9K 0.3% 89
2021
Q4
$2.12M Buy
12,393
+143
+1% +$23.4K 0.28% 100
2021
Q3
$1.98M Buy
12,250
+70
+0.6% +$11.9K 0.29% 100
2021
Q2
$2.01M Sell
12,180
-1,487
-11% -$246K 0.3% 95
2021
Q1
$2.25M Sell
13,667
-435
-3% -$70.4K 0.38% 73
2020
Q4
$2.22M Buy
14,102
+1,113
+9% +$164K 0.43% 63
2020
Q3
$1.93M Sell
12,989
-547
-4% -$80.9K 0.47% 53
2020
Q2
$1.9M Sell
13,536
-210
-2% -$30.6K 0.63% 42
2020
Q1
$2.08M Buy
13,746
+2,786
+25% +$395K 0.74% 36
2019
Q4
$1.65M Buy
10,960
+246
+2% +$33.4K 0.49% 52
2019
Q3
$1.39M Sell
10,714
-5
-0% -$659 0.49% 57
2019
Q2
$1.42M Buy
10,719
+1,246
+13% +$172K 0.54% 51
2019
Q1
$1.32M Buy
9,473
+387
+4% +$51.8K 0.54% 47
2018
Q4
$1.17M Sell
9,086
-6,564
-42% -$916K 0.57% 42
2018
Q3
$2.16M Buy
15,650
+1,120
+8% +$149K 0.61% 34
2018
Q2
$1.76M Buy
14,530
+1,631
+13% +$203K 0.54% 35
2018
Q1
$1.65M Buy
12,899
+1,569
+14% +$212K 0.57% 33
2017
Q4
$1.58M Sell
11,330
-75
-0.7% -$10.4K 0.57% 37
2017
Q3
$1.48M Buy
11,405
+640
+6% +$84.8K 0.59% 34
2017
Q2
$1.42M Sell
10,765
-252
-2% -$32.1K 0.61% 38
2017
Q1
$1.37M Sell
11,017
-147
-1% -$17.6K 0.62% 38
2016
Q4
$1.29M Sell
11,164
-1,720
-13% -$199K 0.6% 41
2016
Q3
$1.52M Buy
12,884
+554
+4% +$67.2K 0.77% 31
2016
Q2
$1.5M Sell
12,330
-1,216
-9% -$138K 0.77% 33
2016
Q1
$1.47M Buy
13,546
+425
+3% +$44K 0.83% 26
2015
Q4
$1.35M Buy
+13,121
New +$1.32M 0.68% 24

Other funds holding JNJ

Ausdal Financial Partners's JNJ Position: Q1 2026 in Review

Ausdal Financial Partners increased its Johnson & Johnson (JNJ) stake by 15% in Q1 2026, buying an estimated $578K and bringing the position to 19,068 shares worth $4.66M. The position accounts for 0.21% of the portfolio, ranked #121.

Ausdal Financial Partners first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,619 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ausdal Financial Partners held 19,068 shares of Johnson & Johnson worth $4.66M as of Q1 2026.
  • Ausdal Financial Partners bought 2,480 Johnson & Johnson shares in Q1 2026, an estimated $578K.
  • Johnson & Johnson made up 0.21% of Ausdal Financial Partners's portfolio in Q1 2026, its #121 holding.
  • Ausdal Financial Partners first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • 4,619 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.